Copyright (c) 2010 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=viclLatest Financial News for Vical Incorporateden-usWed, 30 Dec 2009 20:29:57 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091230/28839.html?.v=1Allovectin-7 has received a positive opinion from an independent safety review board.yahoo_finance/3250472773Wed, 30 Dec 2009 20:29:57 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12t517hop/*http%3A//www.thestreet.com/_yahoo/story/10653557/1/china-bak-vical-midday-volume-plays.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/3596065359Tue, 29 Dec 2009 17:13:28 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091229/2678_id.html?.v=1After rocketing higher during yesterday's session, swine flu news is helping vaccine maker Vical higher Tuesday.yahoo_finance/3393487141Tue, 29 Dec 2009 14:13:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091229/180919.html?.v=1SAN DIEGO -- Vical Incorporated announced today the publication of data documenting the successful pilot lot production and initiation of animal immunogenicity testing of a Vaxfectin-adjuvanted DNA vaccine for H1N1 influenza before conventional vaccine manufacturers even received the seed virus needed to start production.yahoo_finance/3677732625Tue, 29 Dec 2009 11:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/barrons/rss/SIG=11vobv2p3/*http%3A//online.barrons.com/article/SB126200594147307399.html?ru=yahoo&mod=yahoobarronsStocks in the Spotlight Monday Freddie Mac, Vical, 3Par and Amicas all rose.yahoo_finance/3954292028Mon, 28 Dec 2009 22:16:12 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12kj7861a/*http%3A//www.marketwatch.com/news/story/vical-compugen-lead-drug-stocks/story.aspx?guid=%7BA4A03428%2DE3A1%2D487A%2D945E%2D93F556082DA5%7D&siteid=yhoofDrug stocks edged higher in early action Monday as shares of Vical Inc. rallied on positive news about its gene-based cancer therapy Allovectin-7.yahoo_finance/2304581850Mon, 28 Dec 2009 17:59:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh13542_2009-12-28_16-07-06_sge5br06v_newsml&rpc=44&type=marketsNewsyahoo_finance/1171556327Mon, 28 Dec 2009 16:07:06 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091228/us_vical_safety_review.html?.v=1Vical Inc. said Monday a safety review board recommended the drug developer continue a late-stage clinical trial of its cancer drug candidate Allovectin-7.yahoo_finance/1411743135Mon, 28 Dec 2009 14:29:23 Etc/GMThttp://us.rd.yahoo.com/finance/external/FoxBusiness.com/rss/SIG=14248vm9j/*http%3A//www.foxbusiness.com/story/markets/industries/health-care/vicals-skin-cancer-treatment-gets-positive-review-shares-jump/yahoo_finance/1230346976Mon, 28 Dec 2009 13:36:47 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh11867_2009-12-28_12-39-04_wnbb4367_newsml&rpc=44&type=marketsNewsyahoo_finance/3878618753Mon, 28 Dec 2009 12:39:04 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12t36q5ot/*http%3A//www.thestreet.com/_yahoo/story/10652924/1/amicas-limelight-early-volume-plays.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/47624495Mon, 28 Dec 2009 12:28:02 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091228/180853.html?.v=1SAN DIEGO -- Vical Incorporated today announced that an independent Safety Monitoring Board for the company's Phase 3 AIMM trial of Allovectin-7 in patients with metastatic melanoma has completed the trial's third scheduled safety analysis and recommended that the trial continue per the protocol.yahoo_finance/3496985633Mon, 28 Dec 2009 11:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/video/ts/rss/SIG=12gbvq2a1/*http%3A//www.thestreet.com/_yahoo/story/10652343/1/biotech-stocks-under-5.html?cm_ven=YAHOOV&cm_cat=FREE&cm_ite=NAyahoo_finance/3798066808Wed, 23 Dec 2009 22:03:22 Etc/GMThttp://us.rd.yahoo.com/finance/external/FoxBusiness.com/rss/SIG=12v4bgc9s/*http%3A//www.foxbusiness.com/story/markets/early-morning-movers-amkor-technology-interactive/yahoo_finance/509067897Tue, 22 Dec 2009 14:04:44 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh67852_2009-12-22_13-37-59_sge5bl0da_newsml&rpc=44&type=marketsNewsyahoo_finance/1242621801Tue, 22 Dec 2009 13:37:59 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091222/180738.html?.v=1SAN DIEGO -- Vical Incorporated announced today the issuance of U.S. Patent No. 7,628,993 covering DNA vaccines for herpes simplex virus type 2 . HSV-2 is a sexually transmitted virus which is the leading cause of genital herpes.yahoo_finance/3689086393Tue, 22 Dec 2009 11:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091210/vicl8-k.htmlyahoo_finance/1493509319Thu, 10 Dec 2009 17:19:41 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12ib9g8uj/*http%3A//www.fool.com/investing/general/2009/12/09/5-cold-stocks-heating-up.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3250777702Wed, 9 Dec 2009 19:48:54 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091209/179914.html?.v=1BRUSSELS, Belgium -- Vical Incorporated announced today that the company is addressing an international gathering of pandemic influenza vaccine experts and potential commercial partners to encourage broader use of the company's DNA vaccine technology and Vaxfectin adjuvant.yahoo_finance/2751576858Wed, 9 Dec 2009 11:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=1377bh6gg/*http%3A//www.fool.com/investing/high-growth/2009/12/03/behind-the-business-3-questions-for-vical.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/1996949917Thu, 3 Dec 2009 14:55:12 Etc/GMT